US Stock MarketDetailed Quotes

Radiopharm Theranostics (RADX)

Watchlist
  • 4.270
  • -0.120-2.73%
Close Jun 12 16:00 ET
  • 4.270
  • 0.0000.00%
Post 16:10 ET
50.45MMarket Cap-1.15P/E (TTM)

Radiopharm Theranostics (RADX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2025
(Q2)Dec 31, 2024
(Q1)Sep 30, 2024
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
Cash from discontinued investing activities
Investing cash flow
Cash flow from continuing investing activities
653.31%1.77M
2.59K
3M
79.09%-320K
94.60%-1.53M
Net PPE purchase and sale
--0
----
----
--0
----
----
----
----
-1,548.09%-45.31K
----
Net intangibles purchase and sale
--3M
--2.59K
--3M
--0
----
----
----
----
94.76%-1.49M
----
Net other investing changes
-283.44%-1.23M
----
----
---320K
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
653.31%1.77M
--2.59K
--3M
79.09%-320K
----
----
----
----
94.60%-1.53M
----
Financing cash flow
Cash flow from continuing financing activities
50.45%45.43M
-208.08%-2.14M
38.75M
227.59%30.2M
22.79M
518,000.00%5.18M
-78.52%1.98M
-85.84%9.22M
Net issuance payments of debt
-186.28%-1.9M
----
----
--2.2M
--0
--2.2M
--0
----
--0
----
Net common stock issuance
82.08%53.98M
-99.96%762
--45.84M
194.32%29.65M
--24.46M
--3.14M
-79.01%2.11M
----
-85.61%10.07M
----
Net other financing activities
-302.62%-6.65M
-79.69%-240.79K
---7.09M
-93.13%-1.65M
---1.67M
-16,500.00%-166K
84.31%-134K
----
82.31%-854.76K
----
Cash from discontinued financing activities
Financing cash flow
50.45%45.43M
-208.08%-2.14M
--38.75M
227.59%30.2M
--22.79M
518,000.00%5.18M
-78.52%1.98M
----
-85.84%9.22M
----
Net cash flow
Beginning cash position
58.77%18.58M
2,431.68%46.43M
58.77%18.58M
-56.64%11.7M
-84.75%2.94M
-92.19%1.89M
-91.41%1.83M
-56.64%11.7M
99,486.97%26.98M
-38.20%19.27M
Current changes in cash
52.97%10.56M
-14,602.53%-10.88M
386.45%28.27M
144.48%6.9M
305.76%15.75M
119.63%979K
-97.63%75K
-63.46%-9.87M
-157.84%-15.51M
-76.83%-7.66M
Effect of exchange rate changes
40.59%-14.87K
5,985.32%882.8K
-13,800.00%-411K
-110.67%-25.04K
-232.56%-114K
622.22%65K
94.14%-15K
-99.24%3K
84.22%234.65K
-34.85%86K
End cash Position
56.75%29.12M
1,823.81%36.44M
2,431.68%46.43M
58.77%18.58M
58.77%18.58M
-84.75%2.94M
-92.19%1.89M
-91.41%1.83M
-56.64%11.7M
-56.64%11.7M
Free cash flow
-59.50%-36.65M
-358.76%-8.74M
-36.57%-13.48M
7.10%-22.98M
8.01%-7.04M
-19.97%-4.2M
68.30%-1.91M
-63.46%-9.87M
35.35%-24.73M
-76.83%-7.66M
Currency Unit
AUD
AUD
AUD
AUD
AUD
AUD
AUD
AUD
AUD
AUD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Jun 30, 2025(Q2)Dec 31, 2024(Q1)Sep 30, 2024(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
Cash from discontinued investing activities
Investing cash flow
Cash flow from continuing investing activities 653.31%1.77M2.59K3M79.09%-320K94.60%-1.53M
Net PPE purchase and sale --0----------0-----------------1,548.09%-45.31K----
Net intangibles purchase and sale --3M--2.59K--3M--0----------------94.76%-1.49M----
Net other investing changes -283.44%-1.23M-----------320K------------------------
Cash from discontinued investing activities
Investing cash flow 653.31%1.77M--2.59K--3M79.09%-320K----------------94.60%-1.53M----
Financing cash flow
Cash flow from continuing financing activities 50.45%45.43M-208.08%-2.14M38.75M227.59%30.2M22.79M518,000.00%5.18M-78.52%1.98M-85.84%9.22M
Net issuance payments of debt -186.28%-1.9M----------2.2M--0--2.2M--0------0----
Net common stock issuance 82.08%53.98M-99.96%762--45.84M194.32%29.65M--24.46M--3.14M-79.01%2.11M-----85.61%10.07M----
Net other financing activities -302.62%-6.65M-79.69%-240.79K---7.09M-93.13%-1.65M---1.67M-16,500.00%-166K84.31%-134K----82.31%-854.76K----
Cash from discontinued financing activities
Financing cash flow 50.45%45.43M-208.08%-2.14M--38.75M227.59%30.2M--22.79M518,000.00%5.18M-78.52%1.98M-----85.84%9.22M----
Net cash flow
Beginning cash position 58.77%18.58M2,431.68%46.43M58.77%18.58M-56.64%11.7M-84.75%2.94M-92.19%1.89M-91.41%1.83M-56.64%11.7M99,486.97%26.98M-38.20%19.27M
Current changes in cash 52.97%10.56M-14,602.53%-10.88M386.45%28.27M144.48%6.9M305.76%15.75M119.63%979K-97.63%75K-63.46%-9.87M-157.84%-15.51M-76.83%-7.66M
Effect of exchange rate changes 40.59%-14.87K5,985.32%882.8K-13,800.00%-411K-110.67%-25.04K-232.56%-114K622.22%65K94.14%-15K-99.24%3K84.22%234.65K-34.85%86K
End cash Position 56.75%29.12M1,823.81%36.44M2,431.68%46.43M58.77%18.58M58.77%18.58M-84.75%2.94M-92.19%1.89M-91.41%1.83M-56.64%11.7M-56.64%11.7M
Free cash flow -59.50%-36.65M-358.76%-8.74M-36.57%-13.48M7.10%-22.98M8.01%-7.04M-19.97%-4.2M68.30%-1.91M-63.46%-9.87M35.35%-24.73M-76.83%-7.66M
Currency Unit AUDAUDAUDAUDAUDAUDAUDAUDAUDAUD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
The U.S.-Iran negotiations have entered a critical window! According to Bloomberg, both sides are close to signing a memorandum of understan Show More